Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities
Cancer Genomics - Proteomics · 2023
DOI: 10.21873/cgp.20413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Ulrich H Weidle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de.
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland fabian.birzele@roche.com.
Zitieren
APA
Weidle, U. H., & Birzele, F. (2023). Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20413
Vancouver
Weidle UH, Birzele F. Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20413
BibTeX
@article{Weidle2023,
author = {Weidle, Ulrich H and Birzele, Fabian},
title = {Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities},
journal = {Cancer Genomics - Proteomics},
year = {2023},
doi = {10.21873/cgp.20413}
}
EUVIMED